Identifying Difficult-to-Treat Depression: Differential Diagnosis, Subtypes, and Comorbidities
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Article AbstractTreatment-resistant depression (TRD) is a common clinical presentation responsible for much of the burden of major depressive disorder worldwide. For this reason, TRD requires aggressive identification and management. Although several models have been proposed to describe TRD,consensus is still needed on the criteria (ie, dose, duration,compliance, number of trials required) used to define treatment response and resistance. When diagnosing patients with depression,clinicians should identify risk factors associated with treatment resistance, including clinical subtypes of depression and medical or psychiatric comorbidities that could affect the course of treatment.When evaluating a patient who has not responded to a first course of antidepressant treatment, the clinician should verify the primary diagnosis and ensure that the patient has adhered to a treatment regimen that was of adequate dose and duration. From the Department of Psychiatry and the UNCRegional Center for STAR*D,University of North Carolina School of Medicine, ChapelHill.This article is derived from the planning teleconference series"Tackling Partial Remission to Depression Treatment," which was held inMarch and April 2009 and supported by an educational grant fromBristol-Myers Squibb Company and Otsuka America Pharmaceutical,Inc. DrGaynes is a consultant for Bristol-Myers Squibb and has receivedgrant/research support from the National Institute of Mental Health, the Agency for Healthcare Research and Quality, M3 Corporation, Bristol-Myers Squibb, and Novartis.Corresponding author: Bradley Gaynes, MD, MPH, University of NorthCarolina School of Medicine, 101 Manning Dr, Chapel Hill, NC 27514(bradley_gaynes@med.unc.edu).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“Comorbid medical conditions are a risk factor for nonresponse to treatment and for recurrent depressive episodes, underscoring the need for a complete patient history and physical and laboratory evaluation.(31,32) Further, Iosifescu et al(33) showed that the correlation between poor treatment response and medical como…”
BackgroundThe Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Global burden of depressive disorders in the year 2000
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00138-4 · Cited by 590
Nierenberg, A. A., Husain, M. M., Trivedi, M. H., Fava, M., Warden, D., Wisniewski, S. R., Miyahara, S., & Rush, A. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709006011 · Cited by 458
The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs
Crown, W. H., Finkelstein, S., Berndt, E. R., Ling, D., Poret, A. W., Rush, A. J., & Russell, J. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1102 · Cited by 386
Demographic and Clinical Characteristics of Individuals in a Bipolar Disorder Case Registry
Kupfer, D. J., Frank, E., Grochocinski, V. J., Cluss, P. A., Houck, P. R., & Stapf, D. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0206 · Cited by 294 · cited 1×
“In patients with bipolar disorder, depressive symptoms are more prevalent than manic symptoms, making it more likely that a patient will present in a depressive episode.(13,14) Bipolar depressive episodes can be difficult to distinguish from MDD, so obtaining key facts from the patient’s history as well as corroborati…”
BackgroundBerlim, M. T., & Turecki, G. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.009 · Cited by 249 · cited 2×
“= 1 trial ≥ 1 trial = 2 trials = 2 trials with DIFF ADs ≥ 2 trials ≥ 2 trials with DIFF ADs NA 5 (10.6) 8 (17) 6 (12.8) 3 (6.4) 9 (19.1) 8 (17) 8 (17) aReprinted with permission from Berlim and Turecki.5 Abbreviations: DIFF = different classes and/or mechanisms of action, NA = information not available. of suicidal id…”
MethodInfluentialKlein, D. N., Shankman, S. A., & Rose, S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.872 · Cited by 194 · cited 1×
“More than 75% of patients with dysthymic disorder will meet the criteria for a major depressive episode at some point,(20) and this double depression (MDD superimposed on dysthymic disorder) is associated with a high rate of relapse and a protracted course of illness.(21,22) Depressive severity is an important additio…”
BackgroundAngst, J., Gamma, A., Rössler, W., Ajdacic, V., & Klein, D. N. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.09.023 · Cited by 160
Cited by
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Carhart-Harris, R. L., & Goodwin, G. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.84 · Cited by 706
Gaynes, B. N., Lloyd, S. W., Lux, L., Gartlehner, G., Hansen, R. A., Brode, S., Jonas, D. E., Evans, T. S., Viswanathan, M., & Lohr, K. N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08815 · Cited by 347
Self-citationMartin, J. L. R., & Martín-Sánchez, E. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.07.006 · Cited by 102
“In view of the high prevalence of depression, coupled with the high rates of subjects refractory to pharmacological treatments [16,26], the consequences in terms of patients’ health and quality of life [15,24], and the ensuing cost for health care systems [35,47], a coadjuvant non-pharmacological intervention for the…”
BackgroundMore Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
Lyons, T., & Carhart-Harris, R. L. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01721 · Cited by 77
Metadata
- Authors
- Gaynes, B. N.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2009-11
- Volume
- 70
- Issue
- suppl 6
- Pages
- 10-15
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2020472715
- Cited by
- 64
- References
- 12
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.